Extrarenal sites are the major source of erythropoietin (Ep) production in fetuses and neonates. Afterwards, however, the kidneys are the major site. The most likely site of Ep production is the liver, although attempts to extract Ep from the liver have been, to date, unsuccessful. Extrarenal Ep production, as is the case for renal Ep production, is regulated primarily by the oxygen demand: supply. However, some differences have been identified in the response of extrarenal and renal sites of Ep production to several conditions. Two classes of conditions that selectively influence extrarenal Ep production are the subject of this paper. These are the following: 1) factors that cause reparable hepatic injury--including partial hepatectomy, CC14, and bile duct ligation, and 2) continuous perfusion of angiotensin II. The differences between the mechanism by which these two factors influence extrarenal Ep production will be explored and discussed.
Download full-text PDF |
Source |
---|
Invest Ophthalmol Vis Sci
October 2024
Centre de Recherche des Cordeliers, Inserm UMRS1138, Université Paris Cité, Sorbonne Université, Paris, France.
Purpose: Overactivation of the mineralocorticoid receptor (MR) pathway is proinflammatory and contributes to the pathogenesis of diabetic retinopathy and of age-related macular degeneration. Excess of aldosterone, the specific MR ligand, is known to stimulate the production of proinflammatory cytokines and chemokines in extrarenal tissues and cells. In the RPE/choroid complex, aldosterone upregulated genes encoding proteins of the inflammatory response and downregulated genes encoding proteins involved in synaptic activity and neurotransmitters.
View Article and Find Full Text PDFLupus Sci Med
July 2024
Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Objectives: To analyse the response to immunosuppressants (IS) in extrarenal flares of SLE to determine the most appropriate timing during follow-up for a change in therapeutic strategy.
Methods: Observational cohort study including a total of 81 patients with SLE with extrarenal flares requiring a change in IS over the period 2015-2022. Baseline clinical variables were described, and follow-up data at 1, 3, 6 and 12 months time-points were collected.
Int Urol Nephrol
November 2024
Department of Nephrology, Affiliated Hospital of Shandong Second Medical University, 2428 Yuhe Road, Weifang, 261031, Shandong, China.
Chronic kidney disease has emerged as a major health issue both in China and worldwide. Renal anemia frequently occurs in patients with chronic kidney disease, and its severity and incidence rate increase as the disease progresses. Over the last 30 years, the administration of exogenous EPO and EPO stimulants has been employed to alleviate renal anemia, suggesting that a relative deficiency in EPO may be a primary cause.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!